Effect of SGLT2 Inhibitors on the Efficacy of First-Time Pulmonary Vein Isolation and Clinical Course of Patients with Heart Failure with Preserved Ejection Fraction and Atrial Fibrillation
: SGLT2i pharmacotherapy in the study population was linked to higher efficacy in symptom reduction, with a probability of AF recurrence and all-cause mortality reduction, which may suggest a potential beneficial role of SGLT2i in this cohort.
Authors
- Anna Hejmej (ORCID: https://orcid.org/0000-0002-3498-5704)
- Mikołaj Gołda
- Karina Dzięcioł
- Magdalena Balwierz-Podgórna
- Aleksandra Spirkowicz
- Piotr Paździora
- Katarzyna Mizia-Stec
- Bartosz Gruchlik
- Adriana Filak
- Maciej Wybraniec
Institutions
- Medical University of Silesia (PL)
Publication Details
- Journal
- Journal of Cardiovascular Development and Disease
- Published
- 2026-04-06
- DOI
- https://doi.org/10.3390/jcdd13040160
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00